In collaboration with universities throughout the country, Rutgers is developing a plan to protect coastal areas increasingly threatened by extreme weather caused by climate change. Climate scientist and institute core faculty member Robert Kopp is the principal investigator.
Core faculty member Shauna Downs has received a federal grant to study behavior change communication strategies to improve infant and young child nutrition in Senegal.
The curriculum uses health and wellness themes to teach language and literacy acquisition skills to pre-kindergarteners in New Brunswick who are dual-language learners from low-income Latino backgrounds.
Three soon-to-be Rutgers graduates talk about their academic experiences in food science, computational and integrative biology, and nursing, and how global health has played a role.
In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.
Racial disparities in COVID-19 mortality in the U.S. are associated with social factors like income, education, and internet access, according to a Rutgers study published in the Journal of Racial and Ethnic Health Disparities.
Research scientist Maria Laura Gennaro deploys her immunology and microbiology expertise, honed through decades of studying tuberculosis, in the world’s fight against COVID-19.
It’s been seven months since COVID-19 was declared a global pandemic. Rutgers students and faculty discuss the new normal.
Breast cancer is a leading cause of cancer-related deaths in Botswana, and there is a dire need to improve timely access to care. Through research and training, the Botswana-Rutgers Partnership for Health is working to identify and address crucial deficiencies in information and support.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
